There is a growing body of evidence that circulating CD8+ T cells from patients with severe COVID-19 exhibit an activated phenotype characterized by increased expression of CD38, HLA-DR, and Ki-67 [16, 20–22, 107]. Here, CD8A is linked to COVID-19.